We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Otis Worldwide
OTIS
$27.4B
| $211M | 0.54% |
+3,716,333
| New | +$193M |
|
27
Bank of America
BAC
$435B
| $208M | 0.53% |
8,744,386
+841,500
| +11% | +$19.9M |
|
28
Fortive
FTV
$17.9B
| $205M | 0.53% |
4,810,109
+2,855,635
| +146% | +$111M |
|
29
AT&T
T
$159B
| $204M | 0.52% |
8,940,652
+2,614,503
| +41% | +$59.5M |
|
30
ExxonMobil
XOM
$644B
| $202M | 0.52% |
4,519,192
+704,300
| +18% | +$31.6M |
|
31
Coca-Cola
KO
$377B
| $199M | 0.51% |
4,454,482
+32,000
| +0.7% | +$1.47M |
|
|
32
AbbVie
ABBV
$443B
| $199M | 0.51% |
+2,022,311
| New | +$178M |
|
33
Amgen
AMGN
$208B
| $197M | 0.5% |
833,572
+213,700
| +34% | +$48.8M |
|
34
Walmart Inc
WMT
$885B
| $193M | 0.49% |
4,840,035
-1,369,188
| -22% | -$56.3M |
|
35
Lowe's Companies
LOW
$117B
| $191M | 0.49% |
1,412,860
+388,917
| +38% | +$44.4M |
|
|
36
Wayfair
W
$11.2B
| $190M | 0.49% |
+960,000
| New | +$144M |
|
37
Salesforce
CRM
$151B
| $186M | 0.48% |
991,023
-22,200
| -2% | -$3.74M |
|
38
Citigroup
C
$222B
| $182M | 0.47% |
3,553,988
-250,300
| -7% | -$11.9M |
|
|
HZNP
39
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $181M | 0.46% |
+3,255,949
| New | +$139M |
|
40
Verizon
VZ
$195B
| $180M | 0.46% |
3,267,802
-2,125,500
| -39% | -$120M |
|
41
Abbott
ABT
$183B
| $178M | 0.46% |
1,945,952
-79,826
| -4% | -$7.21M |
|
42
Sarepta Therapeutics
SRPT
$1.57B
| $176M | 0.45% |
1,100,000
-925,000
| -46% | -$126M |
|
43
RTX Corp
RTX
$290B
| $173M | 0.44% |
2,810,280
+879,877
| +46% | +$54.9M |
|
44
Merck
MRK
$322B
| $173M | 0.44% |
2,340,400
-623,245
| -21% | -$46.9M |
|
45
Thermo Fisher Scientific
TMO
$213B
| $166M | 0.42% |
457,289
-107,200
| -19% | -$35.9M |
|
46
Accenture
ACN
$102B
| $159M | 0.41% |
740,300
+5,800
| +0.8% | +$1.1M |
|
47
McDonald's
MCD
$192B
| $159M | 0.41% |
861,415
+14,081
| +2% | +$2.58M |
|
48
Fidelity National Information Services
FIS
$23.1B
| $154M | 0.39% |
1,145,750
-341,800
| -23% | -$44.9M |
|
49
Comcast
CMCSA
$85B
| $147M | 0.38% |
3,764,295
-409,061
| -10% | -$15.6M |
|
50
Qualcomm
QCOM
$155B
| $144M | 0.37% |
1,582,160
+347,396
| +28% | +$27.9M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.